NSE · SAILIFE.NS
Sai Life Sciences Limited
₹1,552.00+₹56.30 (+3.76%)
Sai Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 8.54% below the high.
Loading market information…
NSE · ANTHEM.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:02 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Anthem Biosciences Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Anthem Biosciences Ltd.’s next earnings report is currently expected on Dec 2, 2026, with estimated earnings per share of ₹3.50. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Anthem Biosciences Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Anthem Biosciences Ltd. operates as a technology-driven organization specializing in contract research, development, and manufacturing (CRDMO). The company's activities are organized into two primary divisions: CRDMO services and the production of Specialty Ingredients. Through its CRDMO segment, Anthem Biosciences offers comprehensive, full-lifecycle support for both novel chemical and biological entities. This support spans the entire development pipeline, from initial target identification and concept generation, through preclinical evaluation, the creation of development batches for all three phases of clinical trials, and ultimately, commercial-scale manufacturing. Their expertise covers a wide array of advanced therapeutic areas, including RNA-based therapies, antibody-drug conjugates, peptides, oligonucleotides, lipids, biologics, and biotherapeutics. They also employ specialized processes such as fermentation, biosynthesis, biotransformation, and flow chemistry. In its Specialty Ingredients division, Anthem Biosciences manufactures and supplies intricate, fermentation-derived active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2. The company's portfolio also encompasses microbial and mammalian biosimilars, a diverse range of probiotics (such as various species of bacillus, lactobacillus, bifidobacterium, streptococcus, and saccharomyces boulardii), and enzymes. Additionally, they produce key peptides like semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide, alongside nutritional actives, vitamin analogues, and other APIs. The company was established in Bengaluru, India, in 2006.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,552.00+₹56.30 (+3.76%)
Sai Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 8.54% below the high.
₹19,765.00+₹485.00 (+2.52%)
Neuland Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 18.41% below the high.
₹449.00-₹32.35 (-6.72%)
Cohance Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 43.79% below the high.
₹402.05+₹3.45 (+0.87%)
Syngene International Limited’s quoted price sits in the lower half of its reported 52-week range, 40.78% below the high.
₹924.30-₹21.70 (-2.29%)
Jubilant Pharmova Limited’s quoted price sits in the lower half of its reported 52-week range, 21.87% below the high.
₹1,248.80+₹18.20 (+1.48%)
Concord Biotech Limited’s quoted price sits in the lower half of its reported 52-week range, 22.67% below the high.
₹507.60+₹4.05 (+0.8%)
Blue Jet Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 26.27% below the high.
₹513.00+₹27.20 (+5.6%)
SMS Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 2.29% below the high.
